Table 3 reveals that the expression of CRABP2 was not associated with age, gender, degree of differentiation, invasion depth, vascular invasion, nerve invasion, hematogenous metastasis, and postoperative treatment in ESCC (p > 0.05). This evidence concerns the gene CRABP2 and esophageal squamous cell carcinoma.